close and back to page

Latest News

Latest News

Abbott Study: Hospital Nutrition Program Shortens Patient Stays, Reduces Readmissions

For Abbott's study, Advocate Health Care hospitals followed more than 1,200 adults at-risk of malnutrition.

While proper nutrition is vital to staying healthy, its importance becomes more critical for patients recovering in the hospital. A new study by Advocate Health Care and Abbott (No. 14 on the DiversityInc Top 50 Companies list) found that optimizing nutrition care in the hospital could help reduce 30-day readmission rates by 27 percent and the average hospital stay by almost two days for malnourished patients.


Across the U.S., 1 in 3 people enter the hospital malnourished, which can often go unrecognized and undertreated. To help improve care for malnourished patients, Advocate implemented two versions of a nutrition care program – basic and enhanced – at four of its Chicagoland hospitals.

Both programs required care teams to conduct patient malnutrition risk screenings using a validated tool on the hospitals' electronic medical records system, and provide nutrition treatment and support for malnourished or at-risk patients. The enhanced program included more immediate treatment upon hospital admission and follow-up calls to confirm their continued nutrition treatment after leaving the hospital.

Researchers at the four hospitals followed more than 1,200 adults at-risk of malnutrition during their stay to assess the impact of the nutrition programs on the patients' chances of hospital readmissions, as well as their lengths of hospital stays. When compared to the hospitals' previous readmission rates and lengths of stay for malnourished patients, researchers found that using either of the nutrition care programs had an impact, on average, of:

- Reducing the risk of patient readmissions from 22.1 percent to 16.1 percent (27 percent reduction).

- Shortening the risk of a patient's length of stay from 7.2 days to 5.4 days (25 percent reduction).

"Incorporating a simple nutrition care program at hospitals can dramatically accelerate patients' recovery times, and if adopted by providers nationwide, could have tremendous benefits for the health care system at-large," said Krishnan Sriram, MD, tele-intensivist at Advocate Health Care and lead author of the study. "Advocate has been a pioneer in implementing data-driven, value-based care at our hospitals, but it's important for all care providers to consider the effect of even modest interventions, which can significantly improve outcomes while reducing the overall cost of care."

The Value of Nutrition in Hospitals

As hospitals look for ways to improve patient care and reduce readmissions, this study builds on existing research that confirms nutrition can be a simple, cost-effective tool. While nutrition screenings are considered standard-of-care in the hospital, not all use a validated screening tool or implement treatment immediately if someone is considered at-risk. Additionally, when people leave the hospital, many times they do not receive education or follow-up to ensure they are following a nutrition plan to aid their recovery.

"This one-of-a-kind study is leading the way as a model for other hospitals around the world to use nutrition for improving patient care, whether they are in a rural town or urban city," said Suela Sulo, PhD, a health outcomes researcher at Abbott and co-author of the study. "By prioritizing nutrition in the hospital, health care providers can help ensure they are giving their patients the best chances of recovering, and getting them back to living a healthy life."

About the Study:

A Comprehensive Nutrition-focused Quality Improvement Program Reduces 30-day Readmissions and Length of Stay in Hospitalized Patients, published online December 6 in the Journal of Parenteral and Enteral Nutrition, was a multi-site, two-group, pre-post study to evaluate two nutrition Quality Improvement Programs (QIP):

- Two hospitals implemented a basic program (QIPb), which included screening patients for malnutrition using a validated tool and providing treatment (oral nutrition supplements) and nutrition support within 24-48 hours of admission.

- Two hospitals implemented an enhanced program (QIPe), which provided oral nutrition supplements and nutrition support within 24 hours through the hospitals' electronic medical records, and added post-discharge support including instructions, coupons and follow-up phone calls to confirm patients continued taking their oral nutrition supplement.

The study's primary outcome was 30-day unplanned readmissions, with a secondary outcome of hospital length of stay. A total of 1,269 participants aged 18+ at risk of malnutrition were enrolled between October 13, 2014 and April 2, 2015.

The study was funded by Abbott, which had no role in data collection or analysis.

About Advocate Health Care:

Advocate Health Care is the largest health system in Illinois and one of the largest health care providers in the Midwest. Connect with us at www.advocatehealth.com, on Facebook at www.facebook.com/AdvocateHealthCare and on Twitter at @AdvocateHealth.

Abbott: Top Internship for Healthcare and Tech

Interns have spoken: Abbott is the top college internship program for healthcare and tech & engineering.

Originally Published by Abbott.

Abbott recognizes the need to develop its future leaders early, and has been named the top healthcare and tech & engineering internship program by Vault.

Read More Show Less

New Study Shows Abbott's Novel Diagnostic Test Could Help Rule Out Heart Attacks Earlier

Preliminary research indicates that a diagnostic test currently in development, that is done at the patient's side in minutes, has similar accuracy to a high-sensitive troponin test for early rule out of a heart attack .

Originally Published by Abbott.

For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether someone is having a heart attack. New data, published online in JAMA Cardiology, found a new blood test under development that is done right at the patient's side in as little as 15 minutes could identify nearly three-fifths (56.7 percent) of people at low-risk of experiencing a heart attack, similar to the results of a High Sensitive Troponin-I blood test done in the laboratory setting.

Read More Show Less

Abbott: Partnering for a Healthier Future

Abbott supports the First Ladies of Africa in the fight to end AIDS in children and keep mothers healthy.

Originally Published by Abbott.

In countries around the world, Abbott is working across its businesses and in partnerships with others to create healthier futures for families. One example: since 2014, Abbott's diagnostics business has supported the work of the Organization of African First Ladies Against HIV/AIDS (OAFLA – pictured above) to fight the AIDS epidemic in Africa, particularly among pregnant women and children – who are among the most vulnerable populations impacted by the disease.

At an OAFLA meeting on the sidelines of the UN General Assembly in New York City, Abbott and several other organizations are being recognized by OAFLA for longstanding partnership and support, including public-private partnerships that bring together technical, financial and other resources to focus on a global health challenge such as HIV/AIDS.

Read More Show Less

Abbott: DRG Stimulator, A Life Changing Technology for Chronic Pain.

The new technological DRG therapy may be the key to easing daily tasks for those with chronic pain.

Originally Published by Abbott.

Living with chronic pain affects not just your body but also your mind. It can make getting around and getting along equally difficult.

But with innovation in health technology comes hope. Abbott has developed a new device found to be more effective than traditional therapy at relieving chronic pain.

Read More Show Less

Abbott: Expediting Blood Testing With i-Stat

The portable, handheld i-STAT Alinity delivers quick blood test results anywhere you are.

Originally Published by Abbott.

Every day, countless blood samples are tested all around the world for one purpose: to help diagnose and treat medical conditions. From the couple eagerly awaiting the results of a pregnancy blood test to a worried cancer patient hoping for more answers, diagnostic blood tests give vital insight into what's happening underneath the skin.

Read More Show Less

Abbott: Freestyle Libre 14 Day, Now FDA Approved

Abbott's flash glucose monitor now FDA-approved for two weeks of use in U.S. between sensor changes.

Originally Published by Abbott.

The U.S. Food and Drug Administration has approved FreeStyle Libre 14 day— Abbott's revolutionary continuous glucose monitoring system. In the U.S., you can wear the sensor up to 14 days with high accuracy.

Read More Show Less

At Abbott, You Look Like An Engineer

Decades before #ILookLikeAnEngineer, Abbott paved the way for a non-profit dedicated to diversity in STEM.

Originally Published by Abbott.

#ILookLikeAnEngineer.

Remember this? A few years ago, a young software engineer was featured in a recruiting advertisement, only to be accused of not being an actual engineer. Frustrated with the assertion, Isis Wenger started a movement to break the stereotype of what an engineer should look like.

Read More Show Less

Abbott Receives FDA Approval for Next-Generation MitraClip Device to Treat People with Leaky Heart Valves

MitraClip is the gold-standard minimally invasive alternative to open-heart surgery for people needing mitral valve repair.

Originally Published by Abbott.

Abbott announced it received approval from the U.S. Food and Drug Administration (FDA) for a next-generation version of its leading MitraClip® heart valve repair device used to repair a leaky mitral valve without open-heart surgery. The transcatheter clip-based therapy, now on a third generation of product innovations, has been used to treat more than 65,000 patients worldwide over the last ten years.

Read More Show Less